Title  | Date  | Price |
|---|
Forecast of the Key Pipeline Devices to Impact the Medical Equipment Market by 2012
| Dec 2008 |
£2,165 |
Pipeline Insight: Orphan Diseases in Neurology Part III: Myasthenia Gravis
| Nov 2008 |
£6,950 |
Pipeline and Commercial Insight: Schizophrenia - Second generation depots protect market value
| Oct 2008 |
£8,070 |
Pioneer Surgical Technology, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Mindray Medical International Limited Product Pipeline Analysis
| Aug 2008 |
£465 |
Angiotech Pharmaceuticals, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Genzyme Corporation Product Pipeline Analysis
| Aug 2008 |
£465 |
Align Technology, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Theken Spine, LLC Product Pipeline Analysis
| Aug 2008 |
£465 |
AI Medical Devices Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Confluent Surgical Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Shina Systems Ltd. Product Pipeline Analysis
| Aug 2008 |
£465 |
Roche Diagnostics Limited Product Pipeline Analysis
| Aug 2008 |
£465 |
CompuMed, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
DiaGenic ASA Product Pipeline Analysis
| Aug 2008 |
£465 |
KYOCERA Corporation Product Pipeline Analysis
| Aug 2008 |
£465 |
Omrix Biopharmaceuticals, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Amic AB Product Pipeline Analysis
| Aug 2008 |
£465 |
CSMG Technologies, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
AtriCure, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Biotest Diagnostics Corporation Product Pipeline Analysis
| Aug 2008 |
£465 |
Nexa Orthopedics, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Advanced Refractive Technologies, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Alphatec Holdings, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Zimmer Holdings, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Novo Nordisk AS Product Pipeline Analysis
| Aug 2008 |
£465 |
Osmetech plc Product Pipeline Analysis
| Aug 2008 |
£465 |
Hologic, Inc. Product Pipeline Analysis
| Aug 2008 |
£465 |
Innovations and Pipelines for Respiratory Disorders
Niche Markets, New Products and Future Developments
| Aug 2008 |
£2,305 |
Pipeline Insight: Acute Stroke: Commercial Risk Offsets High Unmet Need
| May 2008 |
£6,950 |
U.S. Non-Infectious Disease Vaccine Pipeline
| Apr 2008 |
£3,605 |
Commercial and Pipeline Insight: Hepatitis B
| Oct 2007 |
£9,140 |
Commercial & Pipeline Insight: Hospital Antibacterials A market beyond MRSA
| Aug 2007 |
£9,140 |
Commercial Insight: Antidiabetics Patent expiries and cost containment initiatives balanced by pipeline products
| Aug 2007 |
£9,140 |
Pipeline Insight: Heart failure Week pipeline dominated by new indications and add-on diuretics
| Aug 2007 |
£6,855 |
Indication Expansion
Opportunities for successful lifecycle management
| Mar 2007 |
£1,150 |
Next Generation Protein Engineering and Drug Design
Strategies to boost efficacy and improve drug delivery
| Feb 2007 |
£1,150 |
The Impact of the Phase III Pipeline
Future Projections and Market Disruptions
| Mar 2006 |
£2,105 |
previous
